Cn1c(=O)c2nc(SCC(=O)Nc3ccc(Cl)c(Cl)c3)n(C)c2n(C)c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?